A question of public trust

Number 16

1 January 2007 0

Recent headlines in the UK press have again put the issue of pharmaceutical company sponsorship of cancer initiatives under the spotlight, rekindling the debate about its dangers and its merits. Whenever a non-profit advocacy, patient [more]

UA-77507851-1